10 years of University of Kentucky’s Healthy Hearts for Women takes aim at heart disease

The University of Kentucky will mark a decade of raising awareness and continuing its effort to warn women about the dangers of heart disease with the annual Healthy Hearts for Women Symposium.

Astellas builds its R&D footprint in Cambridge/Boston with an add-on for labs, offices

Astellas is snapping in another piece of the real estate puzzle for its global R&D reorganization. Just as it wraps one project to piece together

August 10, 2023

Data Insights – Pharmaceutical Technology

By Company Name No Filter Selected Bristol-Myers Squibb (697) Merck (512) Novartis (391) AstraZeneca (345) F. Hoffmann-La Roche (297) AbbVie (271) Pfizer (266) BeiGene (216)

November 20, 2023

Sickle Cell Disease patients and the use of disease-modifying treatments

New disease-modifying treatments (DMTs), namely, crizanlizumab, L-glutamine, and voxelotor, have recently been approved.

November 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.